These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30105051)

  • 21. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors.
    Ichihara S; Obata K; Yamada Y; Nagata K; Noda A; Ichihara G; Yamada A; Kato T; Izawa H; Murohara T; Yokota M
    J Mol Cell Cardiol; 2006 Aug; 41(2):318-29. PubMed ID: 16806263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension.
    Lebrasseur NK; Duhaney TA; De Silva DS; Cui L; Ip PC; Joseph L; Sam F
    Hypertension; 2007 Sep; 50(3):489-96. PubMed ID: 17606858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
    Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
    Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
    Iglarz M; Touyz RM; Viel EC; Paradis P; Amiri F; Diep QN; Schiffrin EL
    Hypertension; 2003 Oct; 42(4):737-43. PubMed ID: 12860836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ameliorative role of gemfibrozil against partial abdominal aortic constriction-induced cardiac hypertrophy in rats.
    Singh AP; Singh R; Krishan P
    Cardiol Young; 2015 Apr; 25(4):725-30. PubMed ID: 24905340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction.
    Misaka T; Suzuki S; Miyata M; Kobayashi A; Ishigami A; Shishido T; Saitoh S; Kubota I; Takeishi Y
    Biochem Biophys Res Commun; 2013 Sep; 439(1):142-7. PubMed ID: 23933320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II.
    Li S; Huang B; Zhou C; Shi J; Wu Q; Jiang Q
    Evid Based Complement Alternat Med; 2021; 2021():8857329. PubMed ID: 33510809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy.
    Brigadeau F; Gelé P; Wibaux M; Marquié C; Martin-Nizard F; Torpier G; Fruchart JC; Staels B; Duriez P; Lacroix D
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):408-15. PubMed ID: 17577106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of endostatin overexpression on angiotensin II-induced cardiac hypertrophy in rats.
    Dai YJ; Gong JX; Bian R
    Chin Med J (Engl); 2019 Nov; 132(22):2716-2723. PubMed ID: 31725448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of peroxisome proliferator-activated receptor activators on tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
    Ye P; Fang H; Zhou X; He YL; Liu YX
    Chin Med Sci J; 2004 Dec; 19(4):243-7. PubMed ID: 15669179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
    Liang F; Wang F; Zhang S; Gardner DG
    Endocrinology; 2003 Sep; 144(9):4187-94. PubMed ID: 12933694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atorvastatin attenuating down-regulation of peroxisome proliferator-activated receptor gamma in preventing cardiac hypertrophy of rats in vitro and in vivo.
    Ye P; Sheng L; Zhang C; Liu Y
    J Pharm Pharm Sci; 2006; 9(3):365-75. PubMed ID: 17207419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of TNF-α-mediated NF-κB Activation by Ginsenoside Rg1 Contributes the Attenuation of Cardiac Hypertrophy Induced by Abdominal Aorta Coarctation.
    Tang F; Lu M; Yu L; Wang Q; Mei M; Xu C; Han R; Hu J; Wang H; Zhang Y
    J Cardiovasc Pharmacol; 2016 Oct; 68(4):257-264. PubMed ID: 27195652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II type 2 receptor blockade partially negates antihypertrophic effects of type 1 receptor blockade on pressure-overload rat cardiac hypertrophy.
    Mukawa H; Toki Y; Miyazaki Y; Matsui H; Okumura K; Ito T
    Hypertens Res; 2003 Jan; 26(1):89-95. PubMed ID: 12661917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bawei Chenxiang Wan Ameliorates Cardiac Hypertrophy by Activating AMPK/PPAR-α Signaling Pathway Improving Energy Metabolism.
    Zhang X; Zhang Z; Wang P; Han Y; Liu L; Li J; Chen Y; Liu D; Wang J; Tian X; Zhao Q; Yan F
    Front Pharmacol; 2021; 12():653901. PubMed ID: 34149410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced ADAM17 expression is associated with cardiac remodeling in rats with acute myocardial infarction.
    Zheng DY; Zhao J; Yang JM; Wang M; Zhang XT
    Life Sci; 2016 Apr; 151():61-69. PubMed ID: 26944439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload.
    Tokioka-Akagi T; Fujimori A; Shibasaki M; Inagaki O; Yanagisawa I
    Jpn J Pharmacol; 2001 May; 86(1):79-85. PubMed ID: 11430476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats.
    Jozefowicz E; Brisson H; Rozenberg S; Mebazaa A; Gelé P; Callebert J; Lebuffe G; Vallet B; Bordet R; Tavernier B
    Crit Care Med; 2007 Mar; 35(3):856-63. PubMed ID: 17255874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPAR-γ is involved in the protective effect of 2,3,4',5-tetrahydroxystilbene-2-O-beta-D-glucoside against cardiac fibrosis in pressure-overloaded rats.
    Peng Y; Zeng Y; Xu J; Huang XL; Zhang W; Xu XL
    Eur J Pharmacol; 2016 Nov; 791():105-114. PubMed ID: 27568841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fenofibrate attenuates cardiac and renal alterations in young salt-loaded spontaneously hypertensive stroke-prone rats through mitochondrial protection.
    Castiglioni L; Pignieri A; Fiaschè M; Giudici M; Crestani M; Mitro N; Abbate M; Zoja C; Rottoli D; Foray C; Fiordaliso F; Guerrini U; Tremoli E; Sironi L; Gelosa P
    J Hypertens; 2018 May; 36(5):1129-1146. PubMed ID: 29278547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.